Mustang Bio Statistics

Total Valuation

Mustang Bio has a market cap or net worth of $6.31 million. The enterprise value is $3.77 million.

Market Cap	6.31M
Enterprise Value	3.77M

Important Dates

The next estimated earnings date is Monday, March 10, 2025, after market close.

Earnings Date	Mar 10, 2025
Ex-Dividend Date	n/a

Share Statistics

Mustang Bio has 2.14 million shares outstanding. The number of shares has increased by 151.91% in one year.

Current Share Class	1.29M
Shares Outstanding	2.14M
Shares Change (YoY)	+151.91%
Shares Change (QoQ)	+59.32%
Owned by Insiders (%)	0.16%
Owned by Institutions (%)	5.82%
Float	1.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-0.73
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.40

Current Ratio	0.40
Quick Ratio	0.25
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-21,435.00

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-96.52%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	273.23%
Revenue Per Employee	n/a
Profits Per Employee	-$292,700
Employee Count	80
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -95.43% in the last 52 weeks. The beta is 1.72, so Mustang Bio's price volatility has been higher than the market average.

Beta (5Y)	1.72
52-Week Price Change	-95.43%
50-Day Moving Average	6.59
200-Day Moving Average	12.67
Relative Strength Index (RSI)	32.03
Average Volume (20 Days)	374,605

Short Selling Information

The latest short interest is 127,127, so 5.94% of the outstanding shares have been sold short.

Short Interest	127,127
Short Previous Month	1.85M
Short % of Shares Out	5.94%
Short % of Float	12.10%
Short Ratio (days to cover)	0.18

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.44M
Pretax Income	-40.10M
Net Income	-23.42M
EBITDA	-20.53M
EBIT	-21.44M
Earnings Per Share (EPS)	-$57.54

Full Income Statement

Balance Sheet

The company has $3.53 million in cash and $983,000 in debt, giving a net cash position of $2.54 million or $1.19 per share.

Cash & Cash Equivalents	3.53M
Total Debt	983,000
Net Cash	2.54M
Net Cash Per Share	$1.19
Equity (Book Value)	-8.66M
Book Value Per Share	-5.48
Working Capital	-8.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$16.67 million and capital expenditures -$30,000, giving a free cash flow of -$16.70 million.

Operating Cash Flow	-16.67M
Capital Expenditures	-30,000
Free Cash Flow	-16.70M
FCF Per Share	-$7.80

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Mustang Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-151.91%
Shareholder Yield	-151.91%
Earnings Yield	-370.99%
FCF Yield	-264.54%

Analyst Forecast

The average price target for Mustang Bio is $100.00, which is 3,289.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$100.00
Price Target Difference	3,289.83%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 16, 2025. It was a reverse split with a ratio of 0.02:1.

Last Split Date	Jan 16, 2025
Split Type	Reverse
Split Ratio	0.02:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1